| Product NDC: | 0574-0106 | 
| Proprietary Name: | Bromocriptine mesylate | 
| Non Proprietary Name: | Bromocriptine mesylate | 
| Active Ingredient(s): | 2.5 mg/1 & nbsp; Bromocriptine mesylate | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0574-0106 | 
| Labeler Name: | Paddock Laboratories, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA077646 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20081001 | 
| Package NDC: | 0574-0106-03 | 
| Package Description: | 24 BOTTLE in 1 CARTON (0574-0106-03) > 30 TABLET in 1 BOTTLE | 
| NDC Code | 0574-0106-03 | 
| Proprietary Name | Bromocriptine mesylate | 
| Package Description | 24 BOTTLE in 1 CARTON (0574-0106-03) > 30 TABLET in 1 BOTTLE | 
| Product NDC | 0574-0106 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Bromocriptine mesylate | 
| Dosage Form Name | TABLET | 
| Route Name | ORAL | 
| Start Marketing Date | 20081001 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Paddock Laboratories, Inc. | 
| Substance Name | BROMOCRIPTINE MESYLATE | 
| Strength Number | 2.5 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Ergolines [Chemical/Ingredient],Ergot Derivative [EPC] |